Share Price and Basic Stock Data
Last Updated: December 11, 2025, 1:30 pm
| PEG Ratio | -39.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AksharChem (India) Ltd operates in the dyes and pigments sector, a segment that has faced its fair share of challenges and opportunities. The company’s revenue trajectory has seen fluctuations, with sales reported at ₹335 Cr for FY 2023, a decline from ₹380 Cr in FY 2022. However, the trailing twelve months (TTM) figure shows a modest recovery, reaching ₹357 Cr, suggesting a potential stabilization in revenue streams. Quarterly sales figures also reflect this variability; for instance, sales dipped to ₹64.91 Cr in December 2022 but have since improved to ₹75.28 Cr by December 2023. This indicates a gradual rebound in demand, although still below peak levels. The company’s ability to navigate market fluctuations while maintaining a presence in a competitive industry is crucial for investor confidence.
Profitability and Efficiency Metrics
Profitability metrics for AksharChem display a complex picture. The operating profit margin (OPM) stood at a mere 5% for FY 2023 and has shown signs of improvement, reaching 7% by FY 2025. However, the overall net profit for FY 2023 was a concerning ₹-1 Cr, as the company struggled with rising expenses amid revenue challenges. The interest coverage ratio (ICR) appears robust at 10.02x, indicating that the company can comfortably cover its interest obligations. Yet, the return on equity (ROE) and return on capital employed (ROCE) are notably low, at 1.82% and 3.46%, respectively. This raises questions about the efficiency of capital utilization and profitability, which could be a red flag for prospective investors looking for strong performance metrics.
Balance Sheet Strength and Financial Ratios
AksharChem’s balance sheet reflects a cautious financial strategy, with total borrowings reported at ₹75 Cr against reserves of ₹254 Cr. This gives the company a debt-to-equity ratio that appears manageable, promoting a sense of stability. The cash conversion cycle (CCC) of 67 days suggests reasonable efficiency in managing receivables and inventory, although an increase from previous years indicates a potential slowdown in cash flow. Moreover, the price-to-book value (P/BV) ratio stands at 1.41x, suggesting that the market values the company slightly above its book value. While this is not excessively high, it does imply that investors are willing to pay a premium for the stock, reflecting some level of confidence in the company’s future prospects.
Shareholding Pattern and Investor Confidence
The shareholding structure of AksharChem reveals a strong promoter presence, holding 62.70% of the shares, which can be seen as a stabilizing factor amidst market volatility. However, institutional interest is minimal, with foreign institutional investors (FIIs) at just 0.02% and domestic institutional investors (DIIs) at 0.06%. This lack of institutional backing could raise concerns about broader market confidence in the company. The total number of shareholders has declined from 15,722 in December 2022 to 13,139 by September 2025, suggesting that retail interest may be waning. This trend points to a potential lack of confidence among smaller investors, which could affect the stock’s liquidity and overall valuation if not addressed.
Outlook, Risks, and Final Insight
Looking ahead, AksharChem faces a mixed outlook. The gradual recovery in sales and improving margins are encouraging signs; however, the company must navigate challenges related to profitability and institutional interest. Investors should be aware of risks such as ongoing fluctuations in raw material prices, which could squeeze margins further. Additionally, the company’s low ROE and ROCE raise questions about its operational efficiency and ability to generate returns on investments. While the strong promoter holding offers some reassurance, the lack of institutional backing and the declining number of shareholders could pose challenges to maintaining stock stability. Overall, investors will need to weigh these factors carefully, considering both the potential for recovery and the inherent risks in this dynamic sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AksharChem (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 36.6 Cr. | 121 | 190/68.5 | 20.2 | 162 | 0.83 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 43.2 Cr. | 72.0 | 281/70.7 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 785 Cr. | 635 | 1,148/412 | 20.3 | 91.7 | 0.16 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,690 Cr. | 338 | 572/314 | 35.1 | 62.2 | 1.47 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 53.9 Cr. | 48.0 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,347.23 Cr | 295.51 | 94.69 | 186.93 | 0.40% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 114.51 | 90.52 | 64.91 | 64.74 | 71.68 | 73.30 | 75.28 | 81.79 | 85.91 | 78.93 | 90.69 | 90.74 | 96.96 |
| Expenses | 108.28 | 85.02 | 62.91 | 63.05 | 72.35 | 76.50 | 70.34 | 81.36 | 79.67 | 72.91 | 84.37 | 84.47 | 90.55 |
| Operating Profit | 6.23 | 5.50 | 2.00 | 1.69 | -0.67 | -3.20 | 4.94 | 0.43 | 6.24 | 6.02 | 6.32 | 6.27 | 6.41 |
| OPM % | 5.44% | 6.08% | 3.08% | 2.61% | -0.93% | -4.37% | 6.56% | 0.53% | 7.26% | 7.63% | 6.97% | 6.91% | 6.61% |
| Other Income | 0.04 | 0.01 | 0.02 | 0.07 | 0.04 | 0.02 | 0.28 | 0.10 | 0.06 | 0.22 | 0.07 | -0.09 | 0.04 |
| Interest | 0.98 | 0.82 | 0.74 | 0.67 | 0.80 | 0.88 | 0.98 | 1.07 | 1.25 | 1.32 | 1.34 | 1.36 | 1.43 |
| Depreciation | 3.20 | 3.24 | 3.24 | 3.17 | 3.35 | 3.49 | 3.47 | 3.47 | 3.46 | 3.51 | 3.51 | 3.52 | 3.99 |
| Profit before tax | 2.09 | 1.45 | -1.96 | -2.08 | -4.78 | -7.55 | 0.77 | -4.01 | 1.59 | 1.41 | 1.54 | 1.30 | 1.03 |
| Tax % | 30.62% | 31.72% | -27.55% | -5.77% | 12.55% | 0.79% | 57.14% | 50.37% | 27.67% | 26.24% | 22.08% | -6.92% | 31.07% |
| Net Profit | 1.46 | 0.98 | -1.42 | -1.97 | -5.38 | -7.60 | 0.33 | -6.02 | 1.15 | 1.04 | 1.19 | 1.39 | 0.71 |
| EPS in Rs | 1.82 | 1.22 | -1.77 | -2.45 | -6.70 | -9.46 | 0.41 | -7.49 | 1.43 | 1.29 | 1.48 | 1.73 | 0.88 |
Last Updated: August 2, 2025, 12:35 am
Below is a detailed analysis of the quarterly data for AksharChem (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 96.96 Cr.. The value appears strong and on an upward trend. It has increased from 90.74 Cr. (Mar 2025) to 96.96 Cr., marking an increase of 6.22 Cr..
- For Expenses, as of Jun 2025, the value is 90.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 84.47 Cr. (Mar 2025) to 90.55 Cr., marking an increase of 6.08 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.41 Cr.. The value appears strong and on an upward trend. It has increased from 6.27 Cr. (Mar 2025) to 6.41 Cr., marking an increase of 0.14 Cr..
- For OPM %, as of Jun 2025, the value is 6.61%. The value appears to be declining and may need further review. It has decreased from 6.91% (Mar 2025) to 6.61%, marking a decrease of 0.30%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from -0.09 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.13 Cr..
- For Interest, as of Jun 2025, the value is 1.43 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.36 Cr. (Mar 2025) to 1.43 Cr., marking an increase of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 3.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.52 Cr. (Mar 2025) to 3.99 Cr., marking an increase of 0.47 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.03 Cr.. The value appears to be declining and may need further review. It has decreased from 1.30 Cr. (Mar 2025) to 1.03 Cr., marking a decrease of 0.27 Cr..
- For Tax %, as of Jun 2025, the value is 31.07%. The value appears to be increasing, which may not be favorable. It has increased from -6.92% (Mar 2025) to 31.07%, marking an increase of 37.99%.
- For Net Profit, as of Jun 2025, the value is 0.71 Cr.. The value appears to be declining and may need further review. It has decreased from 1.39 Cr. (Mar 2025) to 0.71 Cr., marking a decrease of 0.68 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.88. The value appears to be declining and may need further review. It has decreased from 1.73 (Mar 2025) to 0.88, marking a decrease of 0.85.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:20 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 200 | 188 | 248 | 264 | 323 | 260 | 246 | 380 | 335 | 302 | 346 | 357 |
| Expenses | 112 | 172 | 155 | 171 | 223 | 288 | 234 | 223 | 349 | 319 | 301 | 321 | 332 |
| Operating Profit | 33 | 27 | 32 | 78 | 42 | 34 | 26 | 24 | 32 | 15 | 2 | 25 | 25 |
| OPM % | 23% | 14% | 17% | 31% | 16% | 11% | 10% | 10% | 8% | 5% | 0% | 7% | 7% |
| Other Income | -2 | 3 | 1 | 9 | 7 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 5 |
| Depreciation | 1 | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 12 | 13 | 14 | 14 | 15 |
| Profit before tax | 29 | 24 | 26 | 79 | 43 | 33 | 19 | 17 | 18 | -0 | -16 | 6 | 5 |
| Tax % | 31% | 32% | 36% | 33% | 28% | 32% | 18% | 28% | 11% | 88% | 20% | 18% | |
| Net Profit | 20 | 16 | 17 | 53 | 31 | 23 | 16 | 12 | 16 | -1 | -19 | 5 | 4 |
| EPS in Rs | 40.46 | 21.88 | 22.75 | 72.37 | 37.26 | 27.54 | 19.16 | 15.24 | 19.81 | -1.17 | -23.25 | 5.94 | 5.38 |
| Dividend Payout % | 12% | 16% | 15% | 5% | 9% | 13% | 18% | 23% | 3% | -43% | -2% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -20.00% | 6.25% | 211.76% | -41.51% | -25.81% | -30.43% | -25.00% | 33.33% | -106.25% | -1800.00% | 126.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | 26.25% | 205.51% | -253.27% | 15.70% | -4.63% | 5.43% | 58.33% | -139.58% | -1693.75% | 1926.32% |
AksharChem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | -3% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -21% |
| 3 Years: | -33% |
| TTM: | 136% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 3% |
| 3 Years: | -9% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| Last Year: | 2% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 29 | 64 | 78 | 133 | 230 | 249 | 257 | 271 | 272 | 270 | 251 | 256 | 254 |
| Borrowings | 9 | 24 | 31 | 32 | 0 | 12 | 13 | 15 | 50 | 25 | 52 | 67 | 75 |
| Other Liabilities | 27 | 51 | 39 | 47 | 61 | 47 | 45 | 62 | 76 | 62 | 70 | 85 | 90 |
| Total Liabilities | 70 | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 427 |
| Fixed Assets | 21 | 55 | 56 | 65 | 86 | 126 | 128 | 229 | 231 | 225 | 235 | 232 | 269 |
| CWIP | 0 | 2 | 4 | 9 | 26 | 31 | 62 | 6 | 16 | 17 | 11 | 45 | 15 |
| Investments | 8 | 18 | 22 | 51 | 77 | 21 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 41 | 71 | 72 | 94 | 110 | 138 | 131 | 120 | 159 | 122 | 135 | 139 | 144 |
| Total Assets | 70 | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 427 |
Below is a detailed analysis of the balance sheet data for AksharChem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 254.00 Cr.. The value appears to be declining and may need further review. It has decreased from 256.00 Cr. (Mar 2025) to 254.00 Cr., marking a decrease of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 75.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 67.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 427.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 415.00 Cr. (Mar 2025) to 427.00 Cr., marking an increase of 12.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 37.00 Cr..
- For CWIP, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 30.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 144.00 Cr.. The value appears strong and on an upward trend. It has increased from 139.00 Cr. (Mar 2025) to 144.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 427.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Mar 2025) to 427.00 Cr., marking an increase of 12.00 Cr..
Notably, the Reserves (254.00 Cr.) exceed the Borrowings (75.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 24.00 | 3.00 | 1.00 | 46.00 | 42.00 | 22.00 | 13.00 | 9.00 | -18.00 | -10.00 | -50.00 | -42.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 38 | 44 | 20 | 38 | 43 | 42 | 42 | 51 | 39 | 57 | 43 |
| Inventory Days | 49 | 53 | 54 | 102 | 68 | 65 | 104 | 148 | 115 | 99 | 131 | 130 |
| Days Payable | 90 | 111 | 96 | 100 | 70 | 49 | 62 | 97 | 80 | 64 | 88 | 106 |
| Cash Conversion Cycle | -7 | -19 | 2 | 22 | 35 | 59 | 83 | 93 | 86 | 75 | 100 | 67 |
| Working Capital Days | 16 | 8 | 28 | 31 | 56 | 85 | 104 | 75 | 62 | 69 | 55 | 18 |
| ROCE % | 85% | 34% | 27% | 53% | 21% | 13% | 7% | 6% | 6% | 1% | -4% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.75 | 21.88 |
| Diluted EPS (Rs.) | 22.75 | 21.88 |
| Cash EPS (Rs.) | 28.55 | 27.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 116.24 | 97.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 116.24 | 97.70 |
| Revenue From Operations / Share (Rs.) | 256.85 | 273.48 |
| PBDIT / Share (Rs.) | 45.83 | 40.36 |
| PBIT / Share (Rs.) | 40.03 | 35.02 |
| PBT / Share (Rs.) | 35.45 | 30.57 |
| Net Profit / Share (Rs.) | 22.75 | 21.88 |
| NP After MI And SOA / Share (Rs.) | 22.75 | 21.88 |
| PBDIT Margin (%) | 17.84 | 14.75 |
| PBIT Margin (%) | 15.58 | 12.80 |
| PBT Margin (%) | 13.80 | 11.17 |
| Net Profit Margin (%) | 8.85 | 8.00 |
| NP After MI And SOA Margin (%) | 8.85 | 8.00 |
| Return on Networth / Equity (%) | 19.57 | 22.39 |
| Return on Capital Employeed (%) | 29.32 | 31.30 |
| Return On Assets (%) | 10.72 | 10.92 |
| Long Term Debt / Equity (X) | 0.07 | 0.02 |
| Total Debt / Equity (X) | 0.33 | 0.32 |
| Asset Turnover Ratio (%) | 1.25 | 0.00 |
| Current Ratio (X) | 1.28 | 1.08 |
| Quick Ratio (X) | 0.98 | 0.79 |
| Inventory Turnover Ratio (X) | 6.24 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 15.38 | 15.99 |
| Dividend Payout Ratio (CP) (%) | 12.25 | 12.85 |
| Earning Retention Ratio (%) | 84.62 | 84.01 |
| Cash Earning Retention Ratio (%) | 87.75 | 87.15 |
| Interest Coverage Ratio (X) | 10.02 | 9.07 |
| Interest Coverage Ratio (Post Tax) (X) | 5.97 | 5.56 |
| Enterprise Value (Cr.) | 147.77 | 137.44 |
| EV / Net Operating Revenue (X) | 0.78 | 0.68 |
| EV / EBITDA (X) | 4.41 | 4.66 |
| MarketCap / Net Operating Revenue (X) | 0.63 | 0.57 |
| Retention Ratios (%) | 84.61 | 84.00 |
| Price / BV (X) | 1.41 | 1.62 |
| Price / Net Operating Revenue (X) | 0.63 | 0.57 |
| EarningsYield | 0.13 | 0.13 |
After reviewing the key financial ratios for AksharChem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For Diluted EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For Cash EPS (Rs.), as of Mar 16, the value is 28.55. This value is within the healthy range. It has increased from 27.22 (Mar 15) to 28.55, marking an increase of 1.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 256.85. It has decreased from 273.48 (Mar 15) to 256.85, marking a decrease of 16.63.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 45.83. This value is within the healthy range. It has increased from 40.36 (Mar 15) to 45.83, marking an increase of 5.47.
- For PBIT / Share (Rs.), as of Mar 16, the value is 40.03. This value is within the healthy range. It has increased from 35.02 (Mar 15) to 40.03, marking an increase of 5.01.
- For PBT / Share (Rs.), as of Mar 16, the value is 35.45. This value is within the healthy range. It has increased from 30.57 (Mar 15) to 35.45, marking an increase of 4.88.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For PBDIT Margin (%), as of Mar 16, the value is 17.84. This value is within the healthy range. It has increased from 14.75 (Mar 15) to 17.84, marking an increase of 3.09.
- For PBIT Margin (%), as of Mar 16, the value is 15.58. This value is within the healthy range. It has increased from 12.80 (Mar 15) to 15.58, marking an increase of 2.78.
- For PBT Margin (%), as of Mar 16, the value is 13.80. This value is within the healthy range. It has increased from 11.17 (Mar 15) to 13.80, marking an increase of 2.63.
- For Net Profit Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 16, the value is 19.57. This value is within the healthy range. It has decreased from 22.39 (Mar 15) to 19.57, marking a decrease of 2.82.
- For Return on Capital Employeed (%), as of Mar 16, the value is 29.32. This value is within the healthy range. It has decreased from 31.30 (Mar 15) to 29.32, marking a decrease of 1.98.
- For Return On Assets (%), as of Mar 16, the value is 10.72. This value is within the healthy range. It has decreased from 10.92 (Mar 15) to 10.72, marking a decrease of 0.20.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 15) to 0.07, marking an increase of 0.05.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.33. This value is within the healthy range. It has increased from 0.32 (Mar 15) to 0.33, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 1.25. It has increased from 0.00 (Mar 15) to 1.25, marking an increase of 1.25.
- For Current Ratio (X), as of Mar 16, the value is 1.28. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 15) to 1.28, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 16, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.79 (Mar 15) to 0.98, marking an increase of 0.19.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 6.24. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 6.24, marking an increase of 6.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 15.38. This value is below the healthy minimum of 20. It has decreased from 15.99 (Mar 15) to 15.38, marking a decrease of 0.61.
- For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 12.25. This value is below the healthy minimum of 20. It has decreased from 12.85 (Mar 15) to 12.25, marking a decrease of 0.60.
- For Earning Retention Ratio (%), as of Mar 16, the value is 84.62. This value exceeds the healthy maximum of 70. It has increased from 84.01 (Mar 15) to 84.62, marking an increase of 0.61.
- For Cash Earning Retention Ratio (%), as of Mar 16, the value is 87.75. This value exceeds the healthy maximum of 70. It has increased from 87.15 (Mar 15) to 87.75, marking an increase of 0.60.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 10.02. This value is within the healthy range. It has increased from 9.07 (Mar 15) to 10.02, marking an increase of 0.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 5.97. This value is within the healthy range. It has increased from 5.56 (Mar 15) to 5.97, marking an increase of 0.41.
- For Enterprise Value (Cr.), as of Mar 16, the value is 147.77. It has increased from 137.44 (Mar 15) to 147.77, marking an increase of 10.33.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.68 (Mar 15) to 0.78, marking an increase of 0.10.
- For EV / EBITDA (X), as of Mar 16, the value is 4.41. This value is below the healthy minimum of 5. It has decreased from 4.66 (Mar 15) to 4.41, marking a decrease of 0.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 16, the value is 84.61. This value exceeds the healthy maximum of 70. It has increased from 84.00 (Mar 15) to 84.61, marking an increase of 0.61.
- For Price / BV (X), as of Mar 16, the value is 1.41. This value is within the healthy range. It has decreased from 1.62 (Mar 15) to 1.41, marking a decrease of 0.21.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
- For EarningsYield, as of Mar 16, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 15) which recorded 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AksharChem (India) Ltd:
- Net Profit Margin: 8.85%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.32% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.57% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.97
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 895 (Industry average Stock P/E: 82.86)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.33
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.85%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Akshar House, Mehsana Gujarat 382715 | cs@aksharchemindia.com http://www.aksharchemindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Paru M Jaykrishna | Chairperson & Managing Director |
| Mr. Munjal M Jaykrishna | Joint Managing Director & CEO |
| Mr. Ashok D Barot | Executive Director |
| Mr. Jigar Mukesh Patel | Independent Director |
| Ms. Maitri K Mehta | Independent Director |
| Mr. Nirav K Shah | Independent Director |
| Mr. Sameer S Sinha | Independent Director |
| Mr. Keyur D Gandhi | Independent Director |
| Mr. Sachin M Jaykrishna | Whole Time Director |
FAQ
What is the intrinsic value of AksharChem (India) Ltd?
AksharChem (India) Ltd's intrinsic value (as of 11 December 2025) is 4261.34 which is 1639.32% higher the current market price of 245.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 197 Cr. market cap, FY2025-2026 high/low of 369/193, reserves of ₹254 Cr, and liabilities of 427 Cr.
What is the Market Cap of AksharChem (India) Ltd?
The Market Cap of AksharChem (India) Ltd is 197 Cr..
What is the current Stock Price of AksharChem (India) Ltd as on 11 December 2025?
The current stock price of AksharChem (India) Ltd as on 11 December 2025 is 245.
What is the High / Low of AksharChem (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AksharChem (India) Ltd stocks is 369/193.
What is the Stock P/E of AksharChem (India) Ltd?
The Stock P/E of AksharChem (India) Ltd is 895.
What is the Book Value of AksharChem (India) Ltd?
The Book Value of AksharChem (India) Ltd is 326.
What is the Dividend Yield of AksharChem (India) Ltd?
The Dividend Yield of AksharChem (India) Ltd is 0.31 %.
What is the ROCE of AksharChem (India) Ltd?
The ROCE of AksharChem (India) Ltd is 3.46 %.
What is the ROE of AksharChem (India) Ltd?
The ROE of AksharChem (India) Ltd is 1.82 %.
What is the Face Value of AksharChem (India) Ltd?
The Face Value of AksharChem (India) Ltd is 10.0.